Skip to Content
UW Health SMPH
American Family Children's Hospital
William A. Craig, MD close
William A. Craig, MD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

William A. Craig, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Craig specializes in infectious diseases. His medical interests include antibiotic pharmacokinetics and pharmacodynamics and infectious diseases.


Infectious Diseases

UW Health Clinics

UW Hospital and Clinics
(608) 263-0946 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)

Professional Certifications and Education

Board Certification Internal Medicine
Infectious Diseases
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship University of Wisconsin Hospital and Clinics, Madison, WI
Medical School Tufts University School of Medicine, Boston, MA, 1965


Best Doctors® in America 2014

Best Doctors® in America 2013

Best Doctors® in America 2011

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Lepak AJ Marchillo K Craig WA Andes DR . In Vivo Pharmacokinetics and Pharmacodynamics of the Lantibiotic NAI-107 in a Neutropenic Murine Thigh Infection Model. Antimicrob Agents Chemother. 2015 Feb;59(2):1258-64
[PubMed ID: 25512404]
Craig WA . Editorial commentary: Are blood concentrations enough for establishing pharmacokinetic/pharmacodynamic relationships? Clin Infect Dis. 2014 Apr;58(8):1084-5
[PubMed ID: 24470275]
Lee DG Murakami Y Andes DR Craig WA . Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice. Antimicrob Agents Chemother. 2013 Mar;57(3):1434-41
[PubMed ID: 23295932]
Lepak AJ Marchillo K Pichereau S Craig WA Andes DR . Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model. Antimicrob Agents Chemother. 2012 Nov;56(11):5916-22
[PubMed ID: 22964254]
Craig WA . Optimizing aminoglycoside use. Crit Care Clin. 2011 Jan;27(1):107-21
[PubMed ID: 21144989]
Andes D Craig WA . In vivo pharmacodynamic activity of the glycopeptide dalbavancin. Antimicrob Agents Chemother. 2007 May;51(5):1633-42
[PubMed ID: 17307987]
Craig WA . Overview of newer antimicrobial formulations for overcoming pneumococcal resistance. Am J Med. 2004 Aug 2;117 Suppl 3A:16S-22S
[PubMed ID: 15360093]
Andes D Anon J Jacobs MR Craig WA . Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections. Clin Lab Med. 2004 Jun;24(2):477-502
[PubMed ID: 15177850]
Craig WA . Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am. 2003 Sep;17(3):479-501
[PubMed ID: 14711073]